Mogul Games Group Ltd

MGG

Mogul Games Group Ltd. engages in the business of design and development of its online media platform. The company is headquartered in Melbourne, Victoria and currently employs 3 full-time employees. The company went IPO on 2011-10-19. The principal activities of the Company consists of gaming, esports media and software business. The firm owns and operates mogul.gg tournament platform, which is a an online esports tournament and matchmaking platform with automation for esports titles. The firm operates in two segments: eSports and Unallocated. The eSports segment consists of equity investments and intangible assets and all expenses related to the eSports business. The Unallocated segment consists of corporate, including treasury, corporate, and regulatory expenses arising from operating an entity. The firm's subsidiaries include eSports Nominees Pty Ltd, SEA Esports Pte Ltd, GameGeek Pte Ltd, and GameGeek Pte Ltd.

Trigg Minerals Limited

TMG

Trigg Minerals Ltd. engages in the exploration and development of brine-hosted fertiliser minerals that are critical for the production of high-nutrient food sources. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-10-03. The firm has three SOP projects located approximately 170 kilometers (km) east of Laverton in Western Australia. Its projects include Lake Throssell Project, Lake Yeo Project and Lake Rason Project. The Lake Throssell Project covers an area of approximately 1,085 square kilometers, over 180 kilometers east of Laverton, Western Australia. The Lake Yeo Project lies over 35 km to the south of the Lake Throssell Project and covers an area of approximately 1,915 square kilometers, with over 200 square kilometers of playa area and approximately 130 km of interpreted palaeovalley. The Lake Rason SOP Project is approximately 500 square kilometers of granted tenements and lies approximately 100 km south of the Lake Throssell Project and over 220 km east of Laverton on the Rason Lake Road.

Botanix Pharmaceuticals Ltd

BOT

Botanix Pharmaceuticals Ltd. engages in the development of therapeutics for the treatment of skin diseases. The company is headquartered in Perth, Western Australia. The firm is engaged in the development and commercialization of treatments for common skin diseases and infections. Its lead product is Sofpironium Bromide, for the treatment of primary axillary hyperhidrosis. The firm also has a pipeline of other products in late-stage clinical studies for the treatment of moderate to severe rosacea, dermatitis and acne respectively. The company is also developing a topical antimicrobial product for the eradication of bacteria on the skin surface, initially in patients who are undergoing hemodialysis. Its BTX1503 product is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX1702 product for the treatment of papulopustular rosacea. Its BTX 1204A canine study in Australia and New Zealand for atopic dermatitis. Its BTX1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus.